C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor

Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629)
11/2011
11/17/2011	US20110281355 Differentiation of Human Embryonic Stem Cells
11/17/2011	US20110281354 Bispecific intracellular delivery vehicles
11/17/2011	US20110281353 Composition and Method for Facilitating the Internalization of a Therapeutic Agent into a Cell
11/17/2011	US20110281352 Transplant Storage
11/17/2011	US20110281351 Process for producing laminated high-density cultured artificial tissue, and laminated high-density cultured artificial tissue
11/17/2011	US20110281350 Tissue Processing System and Method
11/17/2011	US20110281349 Insect Desiccation Resistance Genes and Uses Thereof
11/17/2011	US20110281348 Agonist anti-trkc antibodies and methods using same
11/17/2011	US20110281330 Minicells expressing antibodies or derivatives thereof and comprising biologically active compounds
11/17/2011	US20110281323 Novel Fungal Laccases and Uses Thereof
11/17/2011	US20110281303 Polypeptides having acetyl xylan esterase activity and polynucleotides encoding same
11/17/2011	US20110281302 Compositions and methods of treating disease with fgfr fusion proteins
11/17/2011	US20110281301 The secretory capacity in host cells
11/17/2011	US20110281292 Compositions and methods for identifying antigens which elicit an immune response
11/17/2011	US20110281286 Expression vector for establishing highly productive cell and the highly productive cell
11/17/2011	US20110281282 Subpopulations of spore-like cells and uses thereof
11/17/2011	US20110281281 Integration-free human induced pluripotent stem cells from blood
11/17/2011	US20110281273 Method of making dna tag
11/17/2011	US20110281271 Oligoribonucleotide or Peptide Nucleic Acid Capable of Inhibiting Activity of Hepatitis C Virus
11/17/2011	US20110281261 Vectors
11/17/2011	US20110281257 Method for producing beta-santalene
11/17/2011	US20110280930 Products and methods for stimulating an immune response
11/17/2011	US20110280914 Hydrogels crosslinked with gold nanoparticles and methods of making and using thereof
11/17/2011	US20110280913 Methods and Compositions for Delivering Therapeutic Agents in the Treatment of B-Cell Related Disorders
11/17/2011	US20110280910 Novel surface exposed immunoglobulin d-binding protein from moraxella catarrhalis
11/17/2011	US20110280905 Live attenuated chimeric porcine circovirus vaccine
11/17/2011	US20110280904 Generation of virus-like particles and use as panfilovirus vaccine
11/17/2011	US20110280898 Inhbb epitope peptides and vaccines containing the same
11/17/2011	US20110280896 Methods and compositions for tumor vaccination and therapy
11/17/2011	US20110280895 IMMUNOTHERAPEUTIC METHOD USING ALLO-CELLS WHICH CO-EXPRESS CD1d AND TARGET ANTIGEN
11/17/2011	US20110280894 Her2/neu specific t cell receptors
11/17/2011	US20110280892 Toxin conjugated eph receptor antibodies
11/17/2011	US20110280889 High affinity t cell receptor and use thereof
11/17/2011	US20110280888 Antibodies recognizing a carbohydrate containing epitope on cd-43 and cea expressed on cancer cells and methods using same
11/17/2011	US20110280884 Anti-cd98 antibody
11/17/2011	US20110280883 Fully human anti-epidermal growth factor receptor antibodies
11/17/2011	US20110280882 Leukolectins and uses thereof
11/17/2011	US20110280881 Novel anti-hsp90 monoclonal antibody
11/17/2011	US20110280878 Substance specific to human pd-1
11/17/2011	US20110280876 Mutated netrin - 4, fragments thereof and their use as medicines
11/17/2011	US20110280875 Antibodies which bind human cxcr3
11/17/2011	US20110280873 MCP1-Ig FUSION VARIANTS
11/17/2011	US20110280870 Hepatocyte growth factor receptor antagonists and uses thereof
11/17/2011	US20110280862 Gep and drug transporter regulation, cancer therapy and prognosis
11/17/2011	US20110280861 Method for mir-125a in promoting hematopoietic stem cell self renewal and expansion
11/17/2011	US20110280860 Pharmaceutical compositions comprising monoterpenes
11/17/2011	US20110280846 Olfactory epithelial-derived stem cells and methods of use therefor
11/17/2011	US20110280845 Treatment of rheumatoid arthritis using placental stem cells
11/17/2011	US20110280844 Hepatocyte production by forward programming
11/17/2011	US20110280843 Treatment of diseases and disorders using placental stem cells
11/17/2011	US20110280842 Methods of reprogramming cells
11/17/2011	US20110280841 Electroprocessing in Drug Delivery and Cell Encapsulation
11/17/2011	US20110280838 Treatment of intervertebral disc degeneration using human umbilical cord tissue-derived cells
11/17/2011	US20110280836 Compositions for bacterial mediated gene silencing and methods of using the same
11/17/2011	US20110280832 Eotaxin-2 (ccl24) inhibitors in inflammatory, autoimmune, and cardiovascular disorders
11/17/2011	US20110280830 Albumin Fusion Proteins
11/17/2011	US20110280800 Il-1 binding proteins
11/17/2011	US20110280798 Cell Penetrating Peptides for Intracellular Delivery
11/17/2011	DE102010020222A1 Verfahren zur Herstellung einer Organnachbildung, insbesondere eines Funktionsmodells A method of manufacturing a replica organ, in particular a functional model
11/17/2011	CA2800610A1 Differentiation of human embryonic stem cells
11/17/2011	CA2799307A1 Isolated populations of adult renal cells and methods of isolating and using same
11/17/2011	CA2799028A1 Method of creating and sorting fused cells
11/17/2011	CA2798900A1 Bioactive renal cells
11/17/2011	CA2798895A1 Modulation of splenocytes in cell therapy
11/17/2011	CA2797720A1 Humanized and chimeric monoclonal antibodies to cd47
11/16/2011	EP2386639A2 Modified pore-forming protein toxins and use thereof
11/16/2011	EP2386630A1 Thymidine kinase mutants and fusion proteins having thymidine kinase and guanylate kinase activities
11/16/2011	EP2386629A1 Thymidine kinase mutants and fusion proteins having thymidine kinase and guanylate kinase activities
11/16/2011	EP2386627A1 Induction of a mature hepatocyte phenotype
11/16/2011	EP2386626A1 Stability of secondary metabolite mass production through syncronized plant cell cultures
11/16/2011	EP2386576A1 Tumor-specific recognition molecules
11/16/2011	EP2386575A2 Dual specificity antibodies and methods of making and using
11/16/2011	EP2386574A2 Polypeptide variants with altered effector function
11/16/2011	EP2386319A1 Promoters exhibiting endothelial cell specificity and methods of using same
11/16/2011	EP2386310A2 Methods for preserving organs and tissues
11/16/2011	EP1978973B1 Use hedgehog kinase antagonists to inhibit hedgehog signaling and to treat cancer
11/16/2011	EP1883649B1 Hiv vif mutants
11/16/2011	EP1794295B1 Subtilases
11/16/2011	EP1664102B1 Isolated photoprotein mtclytin, and use thereof
11/16/2011	EP1654285B1 Amino acid sequences facilitating penetration of a substance of interest into cells and/or cell nuclei
11/16/2011	EP1646657B1 Antibodies to cd44 vra and methods of use
11/16/2011	EP1553980B1 Nucleic acid and corresponding protein entitled 238p1b2 useful in treatment and detection of cancer
11/16/2011	EP1474508B1 Phytase variants
11/16/2011	CN1789416B Human artificial chromosome containing human antibody lambda light chain
11/16/2011	CN1732266B Plants having modified growth characteristics and a method for making the same
11/16/2011	CN1311820B BASB027 protein and genes from i(Moraxella Catarrhalis), antigens, antibodies, and uses
11/16/2011	CN102245765A Cell transplantation
11/16/2011	CN102245759A Technique for regulating regeneration of tissue or faulty or abnormal part in organ using NELL-1
11/16/2011	CN102245758A Materials and methds to enhance hematopoietic stem cells engraftment procedures
11/16/2011	CN102245757A Stem cell for therapeutic use which is derived from human monocyte, and method for inducing same
11/16/2011	CN102242146A Composition and method for generating induced pluripotent stem cells using the same
11/16/2011	CN102242137A Lactobacillus acidophilus nucleic acid sequences encoding carbohydrate utilization-related proteins and uses therefor
11/16/2011	CN102242135A Rice serine hydroxymethyl transferase protein and function of coding gene thereof
11/16/2011	CN102242134A Cloning of soybean GmSGT (Glycine max serine glyoxylate aminotransferase) gene and 5' UTR (Untranslated Regions) thereof and application thereof
11/16/2011	CN102242131A Eimeria tenella apical membrane antigen 1 (AMA 1) gene and application thereof
11/16/2011	CN102242126A T1R taste receptors and genes encoding same
11/16/2011	CN102242125A BK channel blocker gene, recombinant vector thereof and cloning method thereof
11/16/2011	CN102242119A Rice root-specific promoter Os03g01700 and application thereof
11/16/2011	CN102242113A Specific expression gene of paddy pollen mother cells
11/16/2011	CN102242083A 3D protein monoclonal antibody for resisting novel duck hepatitis virus serotype I

1 ... 306 307 308 309 310 311 312 313 314 315 316 317 318 319 320 321 322 323 324 325 326 ... 1827